174 related articles for article (PubMed ID: 18491103)
1. Quantitative proton magnetic resonance spectroscopy of the normal liver and malignant hepatic lesions at 3.0 Tesla.
Fischbach F; Schirmer T; Thormann M; Freund T; Ricke J; Bruhn H
Eur Radiol; 2008 Nov; 18(11):2549-58. PubMed ID: 18491103
[TBL] [Abstract][Full Text] [Related]
2. Multiple breath-hold proton spectroscopy of human liver at 3T: Relaxation times and concentrations of glycogen, choline, and lipids.
Weis J; Kullberg J; Ahlström H
J Magn Reson Imaging; 2018 Feb; 47(2):410-417. PubMed ID: 28419608
[TBL] [Abstract][Full Text] [Related]
3. 3.0 T proton magnetic resonance spectroscopy of the liver: quantification of choline.
Xu L; Liu B; Huang Y; Liu X; Zhang SW; Xin XG; Zheng JZ
World J Gastroenterol; 2013 Mar; 19(9):1472-7. PubMed ID: 23539666
[TBL] [Abstract][Full Text] [Related]
4. In vivo proton magnetic resonance spectroscopy of large focal hepatic lesions and metabolite change of hepatocellular carcinoma before and after transcatheter arterial chemoembolization using 3.0-T MR scanner.
Kuo YT; Li CW; Chen CY; Jao J; Wu DK; Liu GC
J Magn Reson Imaging; 2004 May; 19(5):598-604. PubMed ID: 15112309
[TBL] [Abstract][Full Text] [Related]
5. In vivo characterisation of soft tissue tumours by 1.5-T proton MR spectroscopy.
Russo F; Mazzetti S; Grignani G; De Rosa G; Aglietta M; Anselmetti GC; Stasi M; Regge D
Eur Radiol; 2012 May; 22(5):1131-9. PubMed ID: 22138734
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic value of 3.0T (1)H MRS with choline-containing compounds ratio (∆CCC) in primary malignant hepatic tumors.
Zhang L; Zhao X; Ouyang H; Wang S; Zhou C
Cancer Imaging; 2016 Aug; 16(1):25. PubMed ID: 27549094
[TBL] [Abstract][Full Text] [Related]
7. In vivo relaxation behavior of liver compounds at 7 Tesla, measured by single-voxel proton MR spectroscopy.
Gajdošík M; Chmelík M; Just-Kukurová I; Bogner W; Valkovič L; Trattnig S; Krššák M
J Magn Reson Imaging; 2014 Dec; 40(6):1365-74. PubMed ID: 24222653
[TBL] [Abstract][Full Text] [Related]
8. Study of single voxel 1H MR spectroscopy of bone tumors: differentiation of benign from malignant tumors.
Zhang J; Cheng K; Ding Y; Liang W; Ding Y; Vanel D; Cheng X
Eur J Radiol; 2013 Dec; 82(12):2124-8. PubMed ID: 22169357
[TBL] [Abstract][Full Text] [Related]
9. Liver metabolite concentrations measured with 1H MR spectroscopy.
Ouwerkerk R; Pettigrew RI; Gharib AM
Radiology; 2012 Nov; 265(2):565-75. PubMed ID: 22891360
[TBL] [Abstract][Full Text] [Related]
10. Characterization of musculoskeletal lesions on 3-T proton MR spectroscopy.
Fayad LM; Barker PB; Jacobs MA; Eng J; Weber KL; Kulesza P; Bluemke DA
AJR Am J Roentgenol; 2007 Jun; 188(6):1513-20. PubMed ID: 17515370
[TBL] [Abstract][Full Text] [Related]
11. Fully navigated 3 T proton magnetic resonance spectroscopy of liver metastases with inner-volume saturation.
Reischauer C; Hock A; Kolokythas O; Binkert CA; Gutzeit A
Abdom Radiol (NY); 2017 Nov; 42(11):2615-2622. PubMed ID: 28523414
[TBL] [Abstract][Full Text] [Related]
12. A feasibility study of quantitative molecular characterization of musculoskeletal lesions by proton MR spectroscopy at 3 T.
Fayad LM; Wang X; Salibi N; Barker PB; Jacobs MA; Machado AJ; Weber KL; Bluemke DA
AJR Am J Roentgenol; 2010 Jul; 195(1):W69-75. PubMed ID: 20566784
[TBL] [Abstract][Full Text] [Related]
13. [In vivo proton MR spectroscopy of normal liver parenchyma: technique and results].
Müller C; Hübner F; Bisdas S; Herzog C; Hammerstingl RM; Ackermann H; Vorbuchner M; Vogl TJ
Rofo; 2006 Nov; 178(11):1128-36. PubMed ID: 17128381
[TBL] [Abstract][Full Text] [Related]
14. Longitudinally monitoring chemotherapy effect of malignant musculoskeletal tumors with in vivo proton magnetic resonance spectroscopy: an initial experience.
Hsieh TJ; Li CW; Chuang HY; Liu GC; Wang CK
J Comput Assist Tomogr; 2008; 32(6):987-94. PubMed ID: 19204465
[TBL] [Abstract][Full Text] [Related]
15. Levels of choline-containing compounds in normal liver and liver metastases of colorectal cancer as recorded by
Ter Voert EEGW; Heijmen L; van Asten JJA; Wright AJ; Nagtegaal ID; Punt CJA; de Wilt JHW; van Laarhoven HWM; Heerschap A
NMR Biomed; 2019 Jan; 32(1):e4035. PubMed ID: 30457686
[TBL] [Abstract][Full Text] [Related]
16. 1H magnetic resonance spectroscopy of invasive cervical cancer: an in vivo study with ex vivo corroboration.
Mahon MM; Williams AD; Soutter WP; Cox IJ; McIndoe GA; Coutts GA; Dina R; deSouza NM
NMR Biomed; 2004 Feb; 17(1):1-9. PubMed ID: 15011245
[TBL] [Abstract][Full Text] [Related]
17. MRS water resonance frequency in childhood brain tumours: a novel potential biomarker of temperature and tumour environment.
Babourina-Brooks B; Wilson M; Arvanitis TN; Peet AC; Davies NP
NMR Biomed; 2014 Oct; 27(10):1222-9. PubMed ID: 25125325
[TBL] [Abstract][Full Text] [Related]
18. Quantitative mapping of total choline in healthy human breast using proton echo planar spectroscopic imaging (PEPSI) at 3 Tesla.
Zhao C; Bolan PJ; Royce M; Lakkadi N; Eberhardt S; Sillerud L; Lee SJ; Posse S
J Magn Reson Imaging; 2012 Nov; 36(5):1113-23. PubMed ID: 22782667
[TBL] [Abstract][Full Text] [Related]
19. An evaluation of motion compensation strategies and repeatability for abdominal (1)H MR spectroscopy measurements in volunteer studies and clinical trials.
Germuska M; Tunariu N; Leach MO; Xu J; Payne GS
NMR Biomed; 2012 Jun; 25(6):859-65. PubMed ID: 22190219
[TBL] [Abstract][Full Text] [Related]
20. The role of relaxation time corrections for the evaluation of long and short echo time 1H MR spectra of the hippocampus by NUMARIS and LCModel techniques.
Jírů F; Dezortová M; Burian M; Hájek M
MAGMA; 2003 Nov; 16(3):135-43. PubMed ID: 14564645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
